Similarly, studies on the CpG Island methylator phenotype (CIMP+) have highlighted the association of SETD2 and DNA methylation in cancer, with gene body hypomethylation and promoter hypermethylation which is in line with our results [45–47]. The gene discussed is SETD2; the disease is cancer.